GVOKE VIALDX FDA approval date

The FDA approved GVOKE VIALDX on 10 Sep 2019.

FDA approval date
10 Sep 2019

Drug identity has not yet been verified against registry records

Also recorded as GLUCAGON

Included trials

No linked trials for this drug yet. Browse all trials

PDUFA dates and FDA decisions

Date as reportedDrug / companyEventConditionEvidence
2019-09-10DayGVOKE VIALDXFDA original application approvalFDA approval decisionNot specifiedOpen original source
Read source excerpt

{"application_number": "NDA212097", "applicant_as_listed_by_fda": "XERIS", "brand_names": ["GVOKE HYPOPEN", "GVOKE KIT", "GVOKE PFS", "GVOKE VIALDX"], "active_ingredients": ["GLUCAGON"], "submission_type": "ORIG", "submission_number": "1", "submission_status": "AP", "submission_status_date": "20190910", "matched_on": "drug record created from this FDA brand name"}

First seen: 06 Oct 2026 · Evidence last checked: 06 Oct 2026